Po-Han Chou

Dr. Po-Han Chou

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2014 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
CCChin Cheng
Chin Cheng
CLChing-Heng Lin
Ching-Heng Lin
YTYi-Wen Tsai
Yi-Wen Tsai
CTChia-Jui Tsai
Chia-Jui Tsai
PCPo-Han Chou
Po-Han Chou
Tsuo-hung LanTsuo-hung Lan
Tsuo-hung Lan
Type 2 diabetes (T2D) has been shown to increase dementia risk, but few studies evaluated the relationship between antidiabetic treatment and dementia. We followed up 67,731 participants who were nondemented, nondiabetic, aged 65 or over at baseline from January 2004 to December 2009, to observe the onset of T2D (median follow-up 2.4 years), and to compare the risk of the development of dementia associated with particular types of antidiabetic medication among participants with T2D who had solely one type of antidiabetic agents throughout the follow-up period (median follow-up for participants with T2D 3.1 years). The hazard ratio for dementia diagnosis in the new-onset T2D participants compared with the non-T2D participants was 1.56 (95%CI: 1.39–2.18). The relative rate of dementia was 5.31 (95% CI: 1.89–14.96) for participants taking thiazolidinediones (n = 28) and 1.22 (95% CI: 0.78–1.91) for those taking sulfonylureas (n = 796) compared to those taking metformin (n = 1,033). The risk of dementia was higher in ever (n = 841) versus never users (n = 4,579) of thiazolidinediones: 1.44 (95% CI: 1.12–1.86). Diabetes is associated with an increased risk of dementia. The risk effect becomes weaker provided that participants take sulfonylureas or metformin rather than thiazolidinediones for a longer period.

1 July 2017 in Psychosomatics
Verified
Journal Article
Closed access
CCChin Cheng
Chin Cheng
CHChieh-Liang Huang
Chieh-Liang Huang
CTChia-Jui Tsai
Chia-Jui Tsai
PCPo-Han Chou
Po-Han Chou
CLChih-Chien Lin
Chih-Chien Lin
CCChin-Kuo Chang
Chin-Kuo Chang

1 January 2016 in General Hospital Psychiatry
Verified
Journal Article
Closed access
CCChe-Sheng Chu
Che-Sheng Chu
CLChih-Kuang Liang
Chih-Kuang Liang
MCMing-Yueh Chou
Ming-Yueh Chou
YLYu-Te Lin
Yu-Te Lin
CHChien-Jen Hsu
Chien-Jen Hsu
CCChin-Liang Chu
Chin-Liang Chu

1 March 2014 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
PCPo-Han Chou
Po-Han Chou
SKShinsuke Koike
Shinsuke Koike
YNYukika Nishimura
Yukika Nishimura
SKShingo Kawasaki
Shingo Kawasaki
YSYoshihiro Satomura
Yoshihiro Satomura
KKKiyoto Kasai
Kiyoto Kasai

15 August 2013 in Psychosomatics
Verified
Journal Article
Closed access
PDF file
PCPo-Han Chou
Po-Han Chou
CLChih-Chien Lin
Chih-Chien Lin
CLChing-Heng Lin
Ching-Heng Lin
CTChia-Jui Tsai
Chia-Jui Tsai
CCChin Cheng
Chin Cheng
Tsuo-hung LanTsuo-hung Lan
Tsuo-hung Lan

1 June 2017 in Journal of Affective Disorders
Verified
Journal Article
Closed access
PCPo-Han Chou
Po-Han Chou
CCChe-Sheng Chu
Che-Sheng Chu
YCYi-Huei Chen
Yi-Huei Chen
Min-Yen HsuMin-Yen Hsu
Min-Yen Hsu
MHMin-Wei Huang
Min-Wei Huang
Tsuo-hung LanTsuo-hung Lan
Tsuo-hung Lan